IMGN853 Is Active in Patients With FRα-Positive Ovarian Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2017-004
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Is Letrozole Needed for Controlled Ovarian Stimulation in Patients With Estrogen Receptor-Positive Breast Cancer?

Gynecological Endocrinology
GynecologyEndocrinologyMetabolismObstetricsDiabetes
2013English

Polypharmacy in Patients With Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Lurbinectedin Is Active in Patients With BRCA1/2 Mutant Breast Cancer

Cancer Discovery
Oncology
2018English

Viral Gene Therapy Active in Ovarian Cancer

Nature Reviews Clinical Oncology
Oncology
2020English

Clinical Response in Patients With Ovarian Cancer Treated With

ecancermedicalscience
Cancer ResearchOncology
2017English

Use of Hepatoprotectors in Patients With Ovarian Cancer

Obshchaya Reanimatologiya
Critical CareIntensive Care Medicine
2015English

VISTA Expression Is Associated With a Favorable Prognosis in Patients With High-Grade Serous Ovarian Cancer

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Neratinib in Adjuvant Treatment of Patients With HER2-positive Breast Cancer — Less Is More?

Oncology in Clinical Practice
Oncology
2019English

Plasma Immune Analytes in Patients With Epithelial Ovarian Cancer

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy